Genetically engineered natural killer (NK) cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically engineered natural killer (NK) cells, covering 2025-10-15 to 2025-10-15. Get the full timeline:
Most recent: Clinical Trial Update: Genetically Engineered Natural Killer (NK) Cells With or Without Atezolizumab for the Treatment of Non-small Cell Lung Cancer Previously Treated With PD-1 and/or PD-L1 Immune Checkpoint Inhibitors [Phase 1]